Forecast: Obstructive Airway Diseases Medicine Use in Germany

In 2023, the usage of obstructive airway disease medication in Germany stood at 54.6 units. From 2024 to 2028, forecasts show a steady increase in usage, from 54.7 to 55.3 units. The annual year-on-year growth rate is minimal, hovering around 0.18% from year to year. The CAGR over the five-year forecast period is approximately 0.27%, indicating a modest but consistent upward trend in medication usage.

Future trends to watch for include:

• The influence of aging population demographics on increased medication demand.
• Technological advancements in treatment options which may impact medication usage patterns.
• Policy changes in healthcare that could affect drug availability or reimbursement.
• Focus on preventative measures and their potential to moderate medication demand.